Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery

References

• TichanskyDSBoughterJDJrHarperJGlattARMadanAKGastric bypass surgery in rats produces weight loss modeling after human gastric bypassObes Surg2008181246125018581193
   PubMedGoogle Scholar
• SamarasTTStormsLHElrickHLongevity, mortality and body weightAgeing Res Rev2002167369112208237
   PubMed Web of Science ®Google Scholar
• AdamsTDGressRESmithSCLong-term mortality after gastric bypass surgeryN Engl J Med200735775376117715409
   PubMed Web of Science ®Google Scholar
• SchauerPRIkramuddinSGourashWRamanathanRLuketichJOutcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesityAnn Surg200023251552910998650
   PubMed Web of Science ®Google Scholar
• ShinACZhengHTownsendRLSigaletDLBerthoudHRMeal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgeryEndocrinology20101511588159720179262
   PubMed Web of Science ®Google Scholar
• MillerADSmithKMMedication and nutrient administration considerations after bariatric surgeryAm J Health Syst Pharm2006631852185716990631
   PubMed Web of Science ®Google Scholar
• BalakumarKRaghavanCVSelvanNTPrasadRHAbduSSelf nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluationColloids Surf B Biointerfaces201311233734324012665
   PubMed Web of Science ®Google Scholar
• TranTHGuoYSongDBrunoRSLuXQuercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailabilityJ Pharm Sci201410384085224464737
   PubMed Web of Science ®Google Scholar
• StylopoulosNHoppinAGKaplanLMRoux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese ratsObesity2009171839184719556976
   PubMed Web of Science ®Google Scholar
• FabbriniESullivanSKleinSObesity and nonalcohol fatty liver disease: biochemical, metabolic, and clinical implicationsHepatology20105167968920041406
   PubMed Web of Science ®Google Scholar
• CacciapuotiFScognamiglioAPalumboRForteRCacciapuotiFSilymarin in non alcoholic fatty liver diseaseWorld J Hepatol2013510911323556042
   PubMedGoogle Scholar
• FehérJLengyelGSilymarin in the prevention and treatment of liver diseases and primary liver cancerCurr Pharm Biotechnol20121321021721466434
   PubMed Web of Science ®Google Scholar
• WooJSKimTSParkJHChiSCFormulation and biopharmaceutical evaluation of silymarin using SMEDDSArch Pharm Res200730828917328246
   PubMed Web of Science ®Google Scholar
• HuangYBTsaiMJWuPCTsaiYHWuYHFangJYElastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechinJ Drug Target20111970971821303222
   PubMed Web of Science ®Google Scholar
• GažákRSvobodováAPsotováJOxidised derivatives of silybin and their antiradical and antioxidant activityBioorg Med Chem2004125677568715465345
   PubMed Web of Science ®Google Scholar
• HsuSHWenCJAl-SuwayehSAHuangYJFangJYFormulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapyNanomedicine (Lond)201381253126923384703
   PubMed Web of Science ®Google Scholar
• ChenCCTsaiTHHuangZRFangJYEffects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokineticsEur J Pharm Biopharm20107447448220060469
   PubMed Web of Science ®Google Scholar
• ZhuJXTangDFengLDevelopment of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochlorideDrug Dev Ind Pharm20133949950622563917
   PubMed Web of Science ®Google Scholar
• TsaiMJHuangYBWuPCOral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluationsJ Pharm Sci201110054755720740670
   PubMed Web of Science ®Google Scholar
• QuinnRComparing rat’s to human’s age: how old is my rat in people years?Nutrition20052177577715925305
   PubMed Web of Science ®Google Scholar
• SjöströmLNarbroKSjöströmCDEffects of bariatric surgery on mortality in Swedish obese subjectsN Engl J Med200735774175217715408
   PubMed Web of Science ®Google Scholar
• ShinACZhengHTownsendRLPattersonLMHolmesGMBerthoudHRLongitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese ratsObes Surg20132353154023269513
   PubMed Web of Science ®Google Scholar
• MeguidMMRamosEFBSuzukiSA surgical rat model of human Roux-en-Y gastric bypassJ Gastrointest Surg2004862163015240001
   PubMed Web of Science ®Google Scholar
• LeightonJABayMKMaldonadoALJohnsonRFSchenkerSSpeegKVThe effect of liver dysfunction on colchicines pharmacokinetics in the ratHepatology1990112102152307399
   PubMed Web of Science ®Google Scholar
• HolmRTønsbergHJørgensenEBAbedinpourPFarsadSMüllertzAInfluence of bile on the absorption of halofantrine from lipid-based formulationsEur J Pharm Biopharm20128128128722465095
   PubMed Web of Science ®Google Scholar
• GuijarroASuzukiSChenCCharacterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in ratsAm J Physiol Regul Integr Comp Physiol200729314741489
   Web of Science ®Google Scholar
• StemmerKBielohubyMGraysonBERoux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male ratsEndocrinology20131542015202423554454
   PubMed Web of Science ®Google Scholar
• WuJWLinLCTsaiTHDrug-drug interactions of silymarin on the perspective of pharmacokineticsJ Ethnopharmacol200912118519319041708
   PubMed Web of Science ®Google Scholar
• SmithAHenriksenBCohenAPharmacokinetic considerations in Roux-en-Y gastric bypass patientsAm J Health Syst Pharm2011682241224722095812
   PubMed Web of Science ®Google Scholar
• ThomasNHolmRMüllertzARadesTIn vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)J Control Release2012160253222405903
   PubMed Web of Science ®Google Scholar
• BaekMKLeeJHChoYHKimHHLeeGWSelf-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrates: preparation and evaluationInt J Nanomedicine2013816717623326192
   PubMed Web of Science ®Google Scholar
• RegeBDKaoJPolliaJEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayersEur J Pharm Sci20021623724612208453
   PubMed Web of Science ®Google Scholar
• LundinPBojrupMLjusberg-WahrenHWestromBLundinSEnhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP)J Pharmacol Exp Ther19972825855909262318
   PubMed Web of Science ®Google Scholar
• von Suesskind-SchwendiMGruberMTouraudDPharmacokinetics of a self-microemulsifying drug delivery system of tacrolimusBiomed Pharmacother20136746947323669280
   PubMed Web of Science ®Google Scholar
• SchrieberSJWenZVourvahisMThe pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic fatty liver disease and correlates with plasma caspase-3/7 activityDrug Metab Dispos2008361909191618566043
   PubMed Web of Science ®Google Scholar
• JavedSKohliKAliMReassessing bioavailability of silymarinAltern Med Rev20111623924921951025
   PubMed Web of Science ®Google Scholar
• BrantleySJOberliesNHKrollDJPaineMFTwo flavonolignans from milk thistle (Silybum maranum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrationsJ Pharmacol Exp Ther20103321081108719934397
   PubMed Web of Science ®Google Scholar
• MekjaruskulCYangYTLeedMGSadgroveMPJayMSripanidkulchaiBNovel formulation strategies for enhancing oral delivery of methoxy-flavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrinInt J Pharm201344511123376503
   PubMed Web of Science ®Google Scholar
• BandyopadhyaySKatareOPSinghBOptimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglyceridesColloids Surf B Biointerfaces2012100506122766282
   PubMed Web of Science ®Google Scholar
• LarsenATOhlssonAGPolentaruttiBOral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitationEur J Pharm Sci20134833935023178440
   PubMed Web of Science ®Google Scholar
• RaoSVAgarwalPShaoJSelf-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In vitro transport studyInt J Pharm2008362101518640797
   PubMed Web of Science ®Google Scholar
• Bernkop-SchnürchANanocarrier systems for oral drug delivery: do we really need them?Eur J Pharm Sci20134927227723537503
   PubMed Web of Science ®Google Scholar
• MüllerRHRungeSRavelliVMehnertWThünemannAFSoutoEBOral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystalsInt J Pharm2006317828916580159
   PubMed Web of Science ®Google Scholar
• PonskyTABrodyFPucciEAlterations in gastrointestinal physiology after Roux-en-Y gastric bypassJ Am Coll Surg200520112513115978453
   PubMed Web of Science ®Google Scholar
• ZhaoGHuangJXueKSiLLiGEnhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibitionEur J Pharm Sci20135042943923981337
   PubMed Web of Science ®Google Scholar
• NielsenFSPetersenKBMüllertzABioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary stateEur J Pharm Biopharm20086955356218294829
   PubMed Web of Science ®Google Scholar
• WeerapolYLimmatvapiratSNunthanidJSriamornsakPSelf-nanoemulsifying drug delivery system of nifedipine: impact of hydrophiliclipophilic balance and molecular structure of mixed surfactantsAAPS Pharm Sci Tech201415456464
   PubMed Web of Science ®Google Scholar
• HeshmatiNChengXEisenbrandGFrickerGEnhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in ratsJ Pharm Sci20131023792379923934779
   PubMed Web of Science ®Google Scholar
• GažákRWalterováDKřenVSilybin and silymarin – new and emerging applications in medicineCurr Med Chem20071431533817305535
   PubMed Web of Science ®Google Scholar
• CroffordLJCOX-1 and COX-2 tissue expression: implications and predictionsJ Rheumatol Suppl19974915199249646
   PubMedGoogle Scholar
• KissLWalterFRBocsikAKinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cellsJ Pharm Sci20131021173118123362123
   PubMed Web of Science ®Google Scholar